ArticleJournal of cellular and molecular medicine2013

Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabine.

Hong-Quan Duong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.